Cranswick PLC
09 October 2007
Cranswick plc ('Cranswick' or 'the Company') - first half trading statement
The overall performance of the Company in the six months to 30 September 2007
has been positive and in line with management's expectations. The sales
performance has been strong with revenue increasing by 22 per cent and most
product categories delivering double digit growth. This has offset additional
costs associated with the outbreak of foot and mouth disease and start up costs
of the new business at Delico.
Cashflow from operating activities continues to be strong enabling significant
investment in new production facilities without increasing borrowings. The major
spend in the period has been on the new premium bacon factory which is
progressing on target. In August the Company took its interest in Cranswick
Gourmet Bacon Limited from 85 per cent to 100 per cent.
The Company intends to announce its interim results on 19 November 2007.
Enquiries:
Cranswick plc
Martin Davey, Chairman 01482 372080 (mobile 07775 576426)
John Lindop, Finance Director 01482 372090 (mobile 07768 362592)
This information is provided by RNS
The company news service from the London Stock Exchange
STMPBRTMMJMBAR
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.